PDS Biotechnology Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About PDS Biotechnology Corp.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
/ 
Frequently asked questions
To buy PDS Biotechnology Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for PDS Biotechnology Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for PDS Biotechnology Corp. is PDSB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
PDS Biotechnology Corp. has its primary listing on NASDAQ (Small cap). You can trade PDS Biotechnology Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, PDS Biotechnology Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include PDS Biotechnology Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like PDS Biotechnology Corp..